Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurosarcoidosis.

Elyse E Lower1, Kenneth L Weiss

  • 1Interstitial Lung Disease and Sarcoidosis Center, University of Cincinnati Medical Center, 3235 Eden Avenue, Cincinnati, OH 45267, USA. elower@ohcmail.com

Clinics in Chest Medicine
|June 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of New Comorbidities After Steroid Use in Patients With Sarcoidosis: An International Cross-Sectional Survey.

Chest·2025
Same author

A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders.

The Lancet. Respiratory medicine·2025
Same author

WASOG Clinical Trial Endpoint Task Force: Executive Summary.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2025
Same author

Pulmonary sarcoidosis clinical trial end-points: a Delphi study.

The European respiratory journal·2025
Same author

Airway involvement in pulmonary sarcoidosis: Clinical and CT features.

Respiratory medicine·2025
Same author

Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis?

The New England journal of medicine·2025
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Neurosarcoidosis, a rare complication of sarcoidosis, presents diagnostic challenges. Advanced imaging and immunosuppressive therapies, including infliximab, offer new treatment avenues for this neurological condition.

Area of Science:

  • Neurology
  • Immunology
  • Radiology

Background:

  • Neurosarcoidosis affects 5-10% of sarcoidosis patients, potentially causing severe complications.
  • Diagnosis often relies on indirect findings from imaging and cerebrospinal fluid analysis.

Purpose of the Study:

  • To review diagnostic modalities and treatment strategies for neurosarcoidosis.
  • To highlight the utility of advanced imaging and emerging therapies.

Main Methods:

  • Review of current literature on neurosarcoidosis diagnosis and treatment.
  • Emphasis on magnetic resonance (MR) imaging, positron emission tomography (PET) scanning, and cerebrospinal fluid (CSF) examination.
  • Discussion of immunosuppressive agents and biologic therapies.

Related Experiment Videos

Main Results:

  • MR imaging is the most sensitive diagnostic technique for neurological involvement.
  • PET scanning and CSF analysis provide complementary diagnostic information.
  • Immunosuppressive agents (methotrexate, cyclophosphamide, azathioprine) and infliximab show therapeutic potential.

Conclusions:

  • Neurosarcoidosis requires a multimodal diagnostic approach.
  • Immunosuppressive therapy and novel agents like infliximab are crucial for managing neurosarcoidosis manifestations.